NEXIEN BIOPHARMA, INC. financial data

Symbol
NXEN on OTC
Location
Glendale, CO
Fiscal year end
30 June
Latest financial report
10-Q - Q1 2025 - 14 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.1% % -82%
Debt-to-equity -101% % 5.4%
Return On Equity 46% % -44%
Return On Assets -4017% % -235%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70,772,196 shares 4.9%
Common Stock, Shares, Outstanding 70,772,196 shares 4.9%
Common Stock, Value, Issued $7,077 USD 4.9%
Weighted Average Number of Shares Outstanding, Basic 70,772,196 shares 6.6%
Weighted Average Number of Shares Outstanding, Diluted 70,772,196 shares 6.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $0 USD
General and Administrative Expense $74,617 USD -40%
Net Income (Loss) Attributable to Parent $188,082 USD 24%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,285 USD -18%
Assets, Current $8,285 USD -42%
Assets $8,285 USD -42%
Liabilities, Current $458,801 USD 35%
Liabilities $458,801 USD 35%
Retained Earnings (Accumulated Deficit) $11,636,041 USD -1.6%
Stockholders' Equity Attributable to Parent $450,516 USD -38%
Liabilities and Equity $8,285 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,230 USD 46%
Net Cash Provided by (Used in) Financing Activities $10,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 70,772,196 shares 4.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $770 USD
Deferred Tax Assets, Valuation Allowance $726,195 USD 5.4%
Deferred Tax Assets, Operating Loss Carryforwards $726,195 USD 5.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $11,178,448 USD 0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%